Advanced

Versican in inflammation and tissue remodelling: the impact on lung disorders.

Andersson Sjöland, Annika LU ; Hallgren, Oskar LU ; Rolandsson Enes, Sara LU ; Weitoft, Maria LU ; Tykesson, Emil LU ; Larsson Callerfelt, Anna-Karin LU ; Rydell-Törmänen, Kristina LU ; Bjermer, Leif LU ; Malmström, Anders LU and Karlsson, Jenny C LU , et al. (2015) In Glycobiology 25(3). p.243-251
Abstract
Versican is a proteoglycan that has many different roles in tissue homeostasis and inflammation. The biochemical structure is comprised of four different types of the core protein with attached glycosaminoglycans that can be sulphated to various extents and has the capacity to regulate differentiation of different cell types, migration, cell adhesion, proliferation, tissue stabilization and inflammation. Versican's regulatory properties are of importance during both homeostasis and changes that lead to disease progression. The glycosaminoglycans that are attached to the core protein are of the chondroitin sulfate/dermatan sulfate type and are known to be important in inflammation through interactions with cytokines and growth factors. For... (More)
Versican is a proteoglycan that has many different roles in tissue homeostasis and inflammation. The biochemical structure is comprised of four different types of the core protein with attached glycosaminoglycans that can be sulphated to various extents and has the capacity to regulate differentiation of different cell types, migration, cell adhesion, proliferation, tissue stabilization and inflammation. Versican's regulatory properties are of importance during both homeostasis and changes that lead to disease progression. The glycosaminoglycans that are attached to the core protein are of the chondroitin sulfate/dermatan sulfate type and are known to be important in inflammation through interactions with cytokines and growth factors. For a more complex understanding of versican it is of importance to study the tissue niche, where the wound healing process in both healthy and diseased conditions take place. In previous studies our group has identified changes in the amount of the multifaceted versican in chronic lung disorders such as asthma, chronic obstructive pulmonary disease and bronchiolitis obliterans syndrome, which could be a result of pathologic, transforming growth factor β driven, on-going remodelling processes. Reversely, the context of versican in its niche is of great importance since versican has been reported to have a beneficial role in other contexts e.g. emphysema. Here we explore the vast mechanisms of versican in healthy lung and in lung disorders. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Glycobiology
volume
25
issue
3
pages
243 - 251
publisher
Oxford University Press
external identifiers
  • pmid:25371494
  • wos:000350902900001
  • scopus:84943261780
ISSN
1460-2423
DOI
10.1093/glycob/cwu120
language
English
LU publication?
yes
id
df6a26b2-c44e-4406-8ec1-2b3e36ecbf2b (old id 4820224)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25371494?dopt=Abstract
date added to LUP
2014-12-01 19:18:53
date last changed
2017-09-24 03:22:14
@article{df6a26b2-c44e-4406-8ec1-2b3e36ecbf2b,
  abstract     = {Versican is a proteoglycan that has many different roles in tissue homeostasis and inflammation. The biochemical structure is comprised of four different types of the core protein with attached glycosaminoglycans that can be sulphated to various extents and has the capacity to regulate differentiation of different cell types, migration, cell adhesion, proliferation, tissue stabilization and inflammation. Versican's regulatory properties are of importance during both homeostasis and changes that lead to disease progression. The glycosaminoglycans that are attached to the core protein are of the chondroitin sulfate/dermatan sulfate type and are known to be important in inflammation through interactions with cytokines and growth factors. For a more complex understanding of versican it is of importance to study the tissue niche, where the wound healing process in both healthy and diseased conditions take place. In previous studies our group has identified changes in the amount of the multifaceted versican in chronic lung disorders such as asthma, chronic obstructive pulmonary disease and bronchiolitis obliterans syndrome, which could be a result of pathologic, transforming growth factor β driven, on-going remodelling processes. Reversely, the context of versican in its niche is of great importance since versican has been reported to have a beneficial role in other contexts e.g. emphysema. Here we explore the vast mechanisms of versican in healthy lung and in lung disorders.},
  author       = {Andersson Sjöland, Annika and Hallgren, Oskar and Rolandsson Enes, Sara and Weitoft, Maria and Tykesson, Emil and Larsson Callerfelt, Anna-Karin and Rydell-Törmänen, Kristina and Bjermer, Leif and Malmström, Anders and Karlsson, Jenny C and Westergren-Thorsson, Gunilla},
  issn         = {1460-2423},
  language     = {eng},
  number       = {3},
  pages        = {243--251},
  publisher    = {Oxford University Press},
  series       = {Glycobiology},
  title        = {Versican in inflammation and tissue remodelling: the impact on lung disorders.},
  url          = {http://dx.doi.org/10.1093/glycob/cwu120},
  volume       = {25},
  year         = {2015},
}